Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Impella Recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock. Lansdale: HAYES, Inc.. Health Technology Brief Publication. 2013 Authors' conclusions Approximately 6% to 15% of patients with acute myocardial infarction (AMI) present with or develop cardiogenic shock (CS) mainly due to left ventricular (LV) dysfunction. Patients with AMI and CS have a high mortality rate of 40% even with early revascularization. Patients who present with AMI are treated initially with pharmacologic agents (diuretics and inotropes), receive supplemental oxygen or ventilatory support, and are prepared for rapid revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Intra-aortic balloon counterpulsation (IABP) is the standard of care for hemodynamic support for patients with CS. Indexing Status Subject indexing assigned by CRD MeSH Cardiac Output, Low; Cardiac Surgical Procedures; Heart-Assist Devicess; Prosthesis Design; Shock, Cardiogenic Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000578 Date abstract record published 29/07/2013 |